Researchers discover that JAM-A protein keeps blood clots in check

May 3, 2012

those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak.

But when an unwanted clot forms in an artery, and an overaccumulation of platelets blocks flow, a or stroke occurs, too often with fatal results.

Heart disease and stroke rank as humankind's top killers, according to the World Health Organization. Ulhas Naik, director of the Delaware Cardiovascular Research Center at the University of Delaware, hopes to help change that grim statistic for the better.

For the past several years, Naik has been leading a research team in the UD Department of Biological Sciences focused on learning more about a protein in blood called junctional A (JAM-A), which is found on the surface of platelets. Naik actually purified and cloned this protein 24 years ago when he was a postdoctoral researcher.

Although a number of different proteins in blood have been shown to slow , JAM-A is a far more powerful clot inhibitor, Naik and his research team have discovered.

The video will load shortly

He and his colleagues recently reported their findings in Blood, the flagship journal of the American Society of . The authors included UD research scientist Meghna Naik and the University of Pennsylvania's Timothy Stalker, research assistant professor, and Dr. Lawrence Brass, professor of medicine. The research is featured on the journal's cover and also is highlighted in a commentary by Jonathan M. Gibbins of the University of Reading in England.

"The JAM-A protein is the natural protection against unwanted clot formation," Naik says. "It is not the only protein in blood with this role, but other proteins are not as strong or as good."

A split-screen video, produced with the aid of an intravital microscope, provides compelling evidence of JAM-A's importance. On the left, scientists can see a blood clot rapidly form and then decrease in size when JAM-A is present. On the right, in the absence of JAM-A, a clot forms and continues to grow unchecked.

Previously, scientists thought JAM-A actually stimulated platelets to form clots. Now that UD research has shown the opposite to be true, the next step, Naik says, is to determine what the actual mechanism is.

"Is JAM-A affecting the formation of the clot or is it affecting the stability of the clot, for example?" Naik asks.

Naik keeps in mind a common scenario described by a local cardiologist. Two patients with heart disease will visit the cardiologist with the same symptoms. The two patients will receive the same treatment, yet one patient will live and one will die from a heart attack. Could the patients' level of JAM-A be the critical difference between life and death, Naik wonders.

Plaque lines the arteries of patients with atherosclerosis like a fur coat. Sometimes, when chunks of these soft plaques break off, platelets rush to the scene to form clots.

"The JAM-A protein moderates blood clotting," Naik notes. "If it's not there, a clot keeps on growing. If people have less JAM-A, then that may be an important biomarker for predicting who is at greatest risk of a heart attack or stroke and taking steps to prevent it."

Explore further: Solving the mystery of blood clotting

Related Stories

Solving the mystery of blood clotting

March 19, 2012
How and when our blood clots is one of those incredibly complex and important processes in our body that we rarely think about. If your blood doesn't clot and you cut yourself, you could bleed to death, if your blood clots ...

Blood cell breakthrough could help treat heart disease

April 27, 2012
(Phys.org) -- Scientists at the University of Reading have made a groundbreaking discovery into the way blood clots are formed, potentially leading to the development of new drugs to treat one of the world's biggest killer ...

Recommended for you

Team finds link between backup immune defense, mutation seen in Crohn's disease

July 27, 2017
Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

Study finds harmful protein on acid triggers a life-threatening disease

July 27, 2017
Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine (BUSM) have begun to unravel the mystery of how acidity influences a small protein called serum ...

CRISPR sheds light on rare pediatric bone marrow failure syndrome

July 27, 2017
Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.

Post-stroke patients reach terra firma with new exosuit technology

July 26, 2017
Upright walking on two legs is a defining trait in humans, enabling them to move very efficiently throughout their environment. This can all change in the blink of an eye when a stroke occurs. In about 80% of patients post-stroke, ...

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.